| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080395A2 Methods and compositions for cancer treatment |
| 09/23/2004 | WO2004080273A2 Compositions and methods for diagnosing and treating prostate cancer |
| 09/23/2004 | WO2004072293A3 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 09/23/2004 | WO2004055198A3 Device and method for in-line blood testing using biochips |
| 09/23/2004 | WO2004037847A3 Hiv envelope-cd4 complexes and hybrids |
| 09/23/2004 | WO2004029277A3 Oligonucleotide conjugates |
| 09/23/2004 | WO2004023973A3 Molecules for diagnostics and therapeutics |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2003100032A3 Dwarfism genes and dwarf plants |
| 09/23/2004 | WO2003096969A3 Novel lambda phage display system and the process |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003020956A3 Nucleid acid compositions conferring herbicide resistance |
| 09/23/2004 | WO2003020907A3 Histamine receptor h4 polynucleotides |
| 09/23/2004 | US20040186281 Nucleotide derivative and DNA microarray |
| 09/23/2004 | US20040186280 Comprises brachyspira membrane protein B (BmpB) for diagnosing and treating swine dysentery; veterinary medicine |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185531 for use in biosensors/bioreactors; for drug screening; solid phase synthesis; genetic engineering |
| 09/23/2004 | US20040185519 Calcium-independent phospholipase A2 induces ischemic ventricular arrhythmias and decreases infarction size |
| 09/23/2004 | US20040185501 Purified human nucleic acid of given sequence; screening for compounds that bind to metabotropic glutamate receptor gene; expression vectors |
| 09/23/2004 | US20040185492 DNA chip, PNA chip, and their preparation methods |
| 09/23/2004 | US20040185491 use of aromatic solvents, alkyl aromatic solvents, halogenated aromatic solvents, halogenated alkyl aromatic solvents, or aromatic ether solvents to achieve deprotection of protected hydroxyl groups; solid phase synthesis |
| 09/23/2004 | US20040185484 by fragmenting DNA; polishing the fragments' ends; ligating to universal adaptors, performing strand displacement and extension of the nicked fragments, purifying the double-stranded ligation products; solid phase synthesis |
| 09/23/2004 | US20040185479 Modified oligonucleotides for use in gene modulation |
| 09/23/2004 | US20040185473 may be released from the surface of the array by activation of a releasable group; solid phase synthesis |
| 09/23/2004 | US20040185466 to detect single nucleotide polymorphisms, genetic mutation, gene expression, forensic identification, disease association, DNA/genomic sequencing and translation/transcription analysis; solid phase synthesis |
| 09/23/2004 | US20040185459 Diagnostic nucleotide/protein sequences for monitoring and identifying restriction fragment length polymorphisms |
| 09/23/2004 | US20040185453 Affinity based methods for separating homologous parental genetic material and uses thereof |
| 09/23/2004 | US20040185450 Comprises nucleotide sequences coding macrophage chemoattractant protein-1 for prevention and treatment of psychological and cell proliferative disorders |
| 09/23/2004 | US20040185447 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics |
| 09/23/2004 | US20040185037 Human E3alpha ubiquitin ligase family |
| 09/23/2004 | DE10308941A1 Monofunktionalisierte Perylentetracarbonsäurebisimide Monofunctional perylenetetracarboxylic acid bisimides |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518783A1 Detection, monitoring and treatment of cancer |
| 09/23/2004 | CA2518782A1 Oligonucleotide mimetics |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/23/2004 | CA2518452A1 Reca-assisted allele specific oligonucleotide extension method for detecting mutations, snps and specific sequences |
| 09/22/2004 | EP1460083A1 High density immobilization of nucleic acids |
| 09/22/2004 | EP1459070A2 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers |
| 09/22/2004 | EP1458886A2 Tripartite molecular beaconsns |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1337546A4 Method for detecting hematopoietic stem cells |
| 09/22/2004 | EP1201678B1 Novel bicyclonucleoside analogues |
| 09/22/2004 | EP1165694B1 4,7-dichlororhodamine dyes useful as molecular probes |
| 09/22/2004 | EP1140963B1 Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid |
| 09/22/2004 | EP1100809B1 Rna targeted 2'-modified oligonucleotides that are conformationally preorganized |
| 09/22/2004 | EP1019520A4 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 09/22/2004 | EP0775149B1 Novel protecting groups and use thereof in an improved process for oligonucleotide synthesis |
| 09/22/2004 | CN1530444A Gene related to blood sugar regulation, protein product and use thereof |
| 09/21/2004 | US6794502 Half-life is determined for deprotection of 5'-oh protecting group at the 5'-terminus of an oligonucleotide post-synthesis |
| 09/21/2004 | US6794499 Bicyclic locked nucleoside analogues |
| 09/21/2004 | US6794491 Polypeptides, their production and use |
| 09/21/2004 | US6794174 Full-length infectious cDNA clones of tick borne flavivirus |
| 09/21/2004 | US6794172 Method for cloning and expression of PpuMI restriction endonuclease and PpuMI methylase in E. coli |
| 09/21/2004 | US6794140 Isolation of nucleic acid |
| 09/21/2004 | US6794138 Comprises in vitro transcription reaction; product used as template; solid phase synthesis |
| 09/21/2004 | CA2319587C Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| 09/16/2004 | WO2004079367A1 Bioarray |
| 09/16/2004 | WO2004079342A2 Use of nucleic acid mimics for internal reference and calibration in a flow cell microarray binding assay |
| 09/16/2004 | WO2004079011A1 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078994A2 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078949A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | WO2004078941A2 Modulation of gene expression using dna-rna hybrids |
| 09/16/2004 | WO2004078939A2 REGULATION OF Mdm2 FUNCTION |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078773A1 Stabilizing proteins for use in personal care, cosmetic, and pharmaceutical products |
| 09/16/2004 | WO2004078772A1 Oligonucleotides for stimulating immune response |
| 09/16/2004 | WO2004078713A2 Morpholino based activity mapping |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004055199A3 A biological sample storage device and method for biological sample contamination testing |
| 09/16/2004 | WO2004055037A3 Process for purifying oligonucleotide synthons |
| 09/16/2004 | WO2004048256A3 Separation of carbon nanotubes dispersed by nucleic acids |
| 09/16/2004 | WO2004041205A3 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 09/16/2004 | WO2004027080A3 Method of extracting nucleic acids from microbial samples |
| 09/16/2004 | WO2004013291A3 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli |
| 09/16/2004 | WO2003089901A3 Methods for preparing libraries of unique tags and related screening methods |
| 09/16/2004 | WO2003089603A3 Cytokine receptor |
| 09/16/2004 | WO2003074657A3 Cold shock inducible expression and production of heterologous polypeptides |
| 09/16/2004 | WO2002068537A3 Fluorescent dye |
| 09/16/2004 | US20040181826 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector |
| 09/16/2004 | US20040181046 Comprises nucleotide sequences coding fungal protein for diagnosis, prevetion and treatment of respiratory system disorders |
| 09/16/2004 | US20040181045 Antisense nucleotide sequences for treatment, diagnosis and prevention of viral and autoimmune disorders |
| 09/16/2004 | US20040180811 Compositions involving M-RIP, and related methods for screening for anti-hypertensive agents, and uses thereof |
| 09/16/2004 | US20040180445 Methods and compositions for purification of nucleic acid from a host cell |
| 09/16/2004 | US20040180409 TLT-1, a novel platelet-associated receptor and uses therefor |
| 09/16/2004 | US20040180401 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 09/16/2004 | US20040180400 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 09/16/2004 | US20040180399 Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 09/16/2004 | US20040180398 Membrane receptor protein for monitoring metabolism and differentiation of cells |
| 09/16/2004 | US20040180378 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 09/16/2004 | US20040180375 AGS proteins and nucleic acid molecules and uses therefor |
| 09/16/2004 | US20040180360 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180355 9-fluorenylmethoxycarbonyl group (FMOC) for solid phase synthesis on optic glass filters; genetic engineering |
| 09/16/2004 | US20040180351 Interfering RNA molecules |
| 09/16/2004 | US20040180339 Comprises nucleotide sequences coding endometrioid carcinoma 1 (ECA1) gene for use in identifying modulator for treatment and prevention of cell proliferative disorders of urogenital systems; cancer diagnosis |
| 09/16/2004 | US20040180326 Avian leukosis viruses and polypeptide display |